University of Washington School of Public Health
Associate Professor, Medicine - Allergy and Infectious Dis.
Fred Hutchinson Cancer Research Center
Dr. Pergam's research focuses on the prevention of infections in patients with cancer, transplant recipients and other immunocompromised populations. He has research programs that are currently evaluating the use of viral kinetics and advanced diagnostics to improve diagnosis of CMV complications and has an interest in the epidemiology and prevention of viral infections in cord blood transplant recipients and other high-risk HCT populations. A major focus is on the immunogenetics of innate responses to Cytomegalovirus (CMV) in hematopoietic cell transplant recipients. Current studies include the evaluation of natural killer-associated KIR and CMV outcomes post-transplant.
As the Associate Director of Infection Control, Dr Pergam is actively involved in the development of new infection control strategies and employee health educational programs. He has active research projects that aim to better understand the epidemiology of nosocomial bacterial infections and respiratory viruses in cancer patients, and is evaluating new strategies to communicate and educate clinical and non-clinical staff in infection control practices.
MD University of Nebraska, 1998
MPH Epidemiology, University of Washington, 2008
In the News
- 140 Seattle-area cancer patients may have been exposed to TB
The Seattle Times, 08/16/2016